https://www.selleckchem.com/pr....oducts/Imatinib-Mesy
RESULTS From the societal perspective, the combined protocol was more effective (13.16 vs 12.26) with less cost ($91,717 vs $92,684) and thus was the dominant strategy over immediate THA. These results were stable across broad ranges for independent model variables. Monte Carlo simulation with 100,000 samples demonstrated that bariatric surgery prior to THA was the preferred cost-effective strategy over 95% of the time from both a societal and payer perspective. CONCLUSION In the morbidly obese patient with end-stage hip OA, b
Like
Comment
Share
